BioSpace News Archive

National Association of Specialty Pharmacy (NASP) shined the spotlight on the NASP Ron Bookman Memorial Scholarship recipients, the very first NASP Innovation Challenge winner and Abstract/Poster award winners during the 2020 Annual Meeting & Expo Virtual Experience

VERTESS (www.vertess.com), a leading healthcare mergers and acquisitions (M&A) advisory firm, today announced the closing of four major Durable Medical Equipment (DME) healthcare transactions in Q2 and Q3 2020, despite challenges brought on by the pandemic.

The Medical Device Epidemiology Network (MDEpiNet) and Medstreaming/M2S have established a strategic collaboration to advance real-world evaluation of medical devices.

Pallativo, a software provider focused exclusively on the hospice and palliative care industry, today unveiled its enhanced comprehensive electronic health records solution for agencies of all sizes, offering market-leading, built-for-purpose agency management tools.

Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today participation and presentations at the following virtual conferences:

Transplant Genomics (TGI), the leading personalized diagnostics company committed to improving organ transplant outcomes worldwide, today announced it is “Lacing Up” with the National Kidney Foundation (NKF) as a National Multi-Market Sponsor of the Kidney Walk

A novel, oral osteoarthritis (OA) medicine being developed by AKL Research and Development (AKLRD) has recruited its first patient into its Phase II human clinical trial being conducted by its partner Nordic Bioscience Clinical Development (NBCD), following the successful completion of Phase I.

Significant progress in establishing COVID-19 PCR-based diagnostic testing business in US 3CL Protease-based saliva test making progress in Israel 3CL Protease inhibitor NLC-001 dietary supplement added to commercial portfolio 2019 convertible note holders and institutional Q1/2020 convertible note holders sign temporary lock-up agreement NEW YORK, REHOVOT, Israel and SINGAPORE, Sept. 18, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Todos Medical Ltd. (OTCQB: TOMDF) , an in vitro

Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, today announces it has appointed Justin Mclarney as Chief Finance Officer, effective September 15, 2020. Dr. Faz Chowdhury, Nemaura Medical’s Chief Executive Officer commented,

Pipeline Therapeutics, a biopharmaceutical company focused on the development and commercialization of first-in-class small molecules for neuroregeneration, today announced the appointment of Lori Lyons-Williams to the company’s Board of Directors. Ms. Lyons-Williams brings more than 20 years of executive and operational experience to Pipeline. “I am thrilled that Lori will be joining the Pipeline board as an indepe